|
10379
|
Bulgarian vaccine
|
Crimean-Congo haemorrhagic fever
|
Hemorrhagic
|
Nairovirus
|
negative-sense, single-stranded RNA
|
Inactivated
|
Preclinical
|
NA
|
1974
|
Union of Soviet Socialist Republics
|
16 years and above
|
NA
|
Subcutaneous
|
Aluminum (aluminium hydroxide)
|
NA
|
Prepared from brain tissue of CCHFV infected newborn mice
|
NA
|
NA
|
NA
|
Zabdeno, Mvabea
|
32461819
|
NA
|
https://www.liebertpub.com/doi/10.1089/biores.2019.0057
|
https://www.ema.europa.eu/en/documents/product-information/zabdeno-epar-product-information_en.pdf
|
|
10380
|
Trivalent combination vaccine
|
Norovirus Infection
|
Gastrointestinal
|
Norovirus
|
positive-sense, single-stranded RNA
|
Virus like particle
|
Preclinical
|
University of Tampere
|
2013
|
Finland
|
NA
|
NA
|
Intramuscular, Intranasal
|
NA
|
GII-4, GI-3 VLP, rVP6
|
Baculovirus expressed noroviruses VLPs
|
NA
|
NA
|
NA
|
NA
|
23922988
|
NA
|
https://www.cdc.gov/norovirus/downloads/global-burden-report.pdf
|
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3724941/
|
|
10381
|
Delta gD-2
|
Genital Herpes
|
Cutaneous
|
Herpes simplex virus
|
double stranded DNA
|
Subunit vaccine
|
Preclinical
|
X-Vax Technology Inc.
|
NA
|
USA
|
NA
|
NA
|
Intramuscular
|
NA
|
Herpes simplex virus 2 glycoprotein D (gD-2)
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
https://www.precisionvaccinations.com/vaccines/herpes-vaccine-candidates
|
https://www.frontiersin.org/articles/10.3389/fmicb.2021.798927/full
|
|
10382
|
EXD-12
|
Genital Herpes
|
Cutaneous
|
Herpes simplex virus
|
double stranded DNA
|
Live-attenuated
|
Preclinical
|
Excell Biotech
|
2018
|
USA
|
14 - 49 years
|
NA
|
NA
|
NA
|
Herpes simplex virus 2 glycoprotein D (gD-2)
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
https://www.precisionvaccinations.com/vaccines/herpes-vaccine-candidates
|
NA
|
|
10383
|
NanoVax
|
Genital Herpes
|
Cutaneous
|
Herpes simplex virus
|
double stranded DNA
|
Subunit vaccine
|
Preclinical
|
BlueWillow Biologics
|
NA
|
USA
|
NA
|
NA
|
Intranasal
|
NA
|
Herpes simplex virus 2 glycoprotein D (gD-2)
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
https://www.precisionvaccinations.com/vaccines/herpes-vaccine-candidates
|
NA
|
|
10384
|
RVx201
|
Genital Herpes
|
Cutaneous
|
Herpes simplex virus
|
double stranded DNA
|
Live-attenuated
|
Preclinical
|
Rational Vaccines Inc.
|
2021
|
UK
|
NA
|
NA
|
NA
|
NA
|
HSV-2 infected cell protein
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
https://www.precisionvaccinations.com/vaccines/herpes-vaccine-candidates
|
NA
|
|
10385
|
DeltaC-CHIKV
|
Chikungunya fever
|
Exanthous
|
Chikungunya virus
|
positive-sense, single-stranded RNA
|
Live-attenuated
|
Preclinical
|
NA
|
NA
|
NA
|
NA
|
Single dose
|
Subcutaneous
|
NA
|
Capsid deletion
|
NA
|
NA
|
NA
|
NA
|
NA
|
31921059
|
NA
|
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930866/
|
NA
|
|
10386
|
Stop CHIKV SuperStop CHIKV
|
Chikungunya fever
|
Exanthous
|
Chikungunya virus
|
positive-sense, single-stranded RNA
|
Live-attenuated
|
Preclinical
|
NA
|
NA
|
NA
|
NA
|
Single dose
|
Footpad injection
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
31921059
|
NA
|
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930866/
|
NA
|
|
10387
|
DRDE-06
|
Chikungunya fever
|
Exanthous
|
Chikungunya virus
|
positive-sense, single-stranded RNA
|
Live-attenuated
|
Preclinical
|
NA
|
NA
|
NA
|
NA
|
3 doses
|
NA
|
NA
|
NA
|
Formalin inactivated produced in vero cells
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
https://academic.oup.com/jid/article/214/suppl_5/S488/2632628
|
NA
|
|
10388
|
CHIK-E1/E2
|
Chikungunya fever
|
Exanthous
|
Chikungunya virus
|
positive-sense, single-stranded RNA
|
Subunit vaccine
|
Preclinical
|
NA
|
NA
|
NA
|
NA
|
3 doses
|
NA
|
NA
|
E1/E2
|
Recombinant E1/E2 produced in E. coli
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
https://academic.oup.com/jid/article/214/suppl_5/S488/2632628
|
NA
|
|
10389
|
CHIK-E2
|
Chikungunya fever
|
Exanthous
|
Chikungunya virus
|
positive-sense, single-stranded RNA
|
Subunit vaccine
|
Preclinical
|
NA
|
NA
|
NA
|
NA
|
2 doses
|
NA
|
NA
|
E1
|
Recombinant E2 produced in E. coli
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
https://academic.oup.com/jid/article/214/suppl_5/S488/2632628
|
NA
|
|
10390
|
VLP-CHIKV-S27
|
Chikungunya fever
|
Exanthous
|
Chikungunya virus
|
positive-sense, single-stranded RNA
|
Virus like particle
|
Preclinical
|
NA
|
NA
|
NA
|
NA
|
2 doses
|
NA
|
NA
|
CHIKV proteins
|
Baculovirus-vectored CHIKV VLPs formulated with adjuvant
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
https://academic.oup.com/jid/article/214/suppl_5/S488/2632628
|
NA
|
|
10391
|
Chimeric alphavirus
|
Chikungunya fever
|
Exanthous
|
Chikungunya virus
|
positive-sense, single-stranded RNA
|
Live-attenuated
|
Preclinical
|
NA
|
NA
|
NA
|
NA
|
Single dose
|
NA
|
NA
|
CHIKV structural proteins
|
Recombinant alphavirus (EEEV, VEEV, SINV) with CHIKV structural proteins
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
https://academic.oup.com/jid/article/214/suppl_5/S488/2632628
|
NA
|
|
10392
|
CHIKV/IRES
|
Chikungunya fever
|
Exanthous
|
Chikungunya virus
|
positive-sense, single-stranded RNA
|
Live-attenuated
|
Preclinical
|
NA
|
NA
|
NA
|
NA
|
Single dose
|
NA
|
NA
|
CHIKV structural proteins
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
https://academic.oup.com/jid/article/214/suppl_5/S488/2632628
|
NA
|
|
10393
|
VSV-CHIKV
|
Chikungunya fever
|
Exanthous
|
Chikungunya virus
|
positive-sense, single-stranded RNA
|
Live-attenuated
|
Preclinical
|
NA
|
NA
|
NA
|
NA
|
Single dose
|
NA
|
NA
|
CHIKV structural proteins
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
https://academic.oup.com/jid/article/214/suppl_5/S488/2632628
|
NA
|
|
10394
|
CAdVax-CHIK
|
Chikungunya fever
|
Exanthous
|
Chikungunya virus
|
positive-sense, single-stranded RNA
|
Recombinant viral vector
|
Preclinical
|
GenPhar Inc.
|
NA
|
NA
|
NA
|
Single dose
|
NA
|
NA
|
CHIKV structural proteins
|
Produced in HEK293 packaging cell line
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
https://academic.oup.com/jid/article/214/suppl_5/S488/2632628
|
https://www.sciencedirect.com/science/article/pii/S0264410X16300731
|
|
10395
|
MVA-CHIKV
|
Chikungunya fever
|
Exanthous
|
Chikungunya virus
|
positive-sense, single-stranded RNA
|
Recombinant viral vector
|
Preclinical
|
NA
|
NA
|
NA
|
NA
|
Single dose
|
NA
|
NA
|
CHIKV structural proteins
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
https://academic.oup.com/jid/article/214/suppl_5/S488/2632628
|
NA
|
|
10396
|
pMCE321
|
Chikungunya fever
|
Exanthous
|
Chikungunya virus
|
positive-sense, single-stranded RNA
|
DNA based vaccine
|
Preclinical
|
NA
|
NA
|
NA
|
NA
|
NA
|
Intramuscular
|
NA
|
Sequence of E3, E2, and E1 genes under a CMV promoter
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
https://academic.oup.com/jid/article/214/suppl_5/S488/2632628
|
NA
|
|
10397
|
iDNA
|
Chikungunya fever
|
Exanthous
|
Chikungunya virus
|
positive-sense, single-stranded RNA
|
DNA based vaccine
|
Preclinical
|
NA
|
NA
|
NA
|
NA
|
NA
|
Intramuscular
|
NA
|
CHIKV strain 181/25
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
https://academic.oup.com/jid/article/214/suppl_5/S488/2632628
|
NA
|
|
10398
|
DREP-Env
|
Chikungunya fever
|
Exanthous
|
Chikungunya virus
|
positive-sense, single-stranded RNA
|
DNA based vaccine
|
Preclinical
|
NA
|
NA
|
NA
|
NA
|
NA
|
Intradermal
|
NA
|
CHIKV replicon (nsP1 to nsP4) and CHIKV envelope proteins (E1, E2, and E3)
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
https://academic.oup.com/jid/article/214/suppl_5/S488/2632628
|
NA
|
|
10399
|
LR-E2-E79 K
|
Chikungunya fever
|
Exanthous
|
Chikungunya virus
|
positive-sense, single-stranded RNA
|
Live-attenuated
|
Preclinical
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
Clinical strain LR attenuated by mutations in heparin sulfate binding domains
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
https://link.springer.com/chapter/10.1007/82_2019_175
|
NA
|
|
10400
|
CHIKV TM17-2
|
Chikungunya fever
|
Exanthous
|
Chikungunya virus
|
positive-sense, single-stranded RNA
|
Live-attenuated
|
Preclinical
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
Clinical strain attenuated by mutations in E2 transmembrane domain
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
https://link.springer.com/chapter/10.1007/82_2019_175
|
NA
|
|
10401
|
CHIKV/IRES
|
Chikungunya fever
|
Exanthous
|
Chikungunya virus
|
positive-sense, single-stranded RNA
|
Live-attenuated
|
Preclinical
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
https://link.springer.com/chapter/10.1007/82_2019_175
|
NA
|
|
10402
|
VSVdelG-CHIKV
|
Chikungunya fever
|
Exanthous
|
Chikungunya virus
|
positive-sense, single-stranded RNA
|
Recombinant viral vector
|
Preclinical
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
Glycoprotein-deficient VSV encoding CHIKV structural proteins
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
https://link.springer.com/chapter/10.1007/82_2019_175
|
NA
|
|
10403
|
VEE/CHIKV
|
Chikungunya fever
|
Exanthous
|
Chikungunya virus
|
positive-sense, single-stranded RNA
|
Recombinant viral vector
|
Preclinical
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
Chimera consisting of VEEV nsP and CHIKV structural proteins
|
NA
|
NA
|
NA
|
NA
|
VEE/IRES-C/CHIKV
|
NA
|
NA
|
https://link.springer.com/chapter/10.1007/82_2019_175
|
NA
|
|
10404
|
EILV/CHIKV
|
Chikungunya fever
|
Exanthous
|
Chikungunya virus
|
positive-sense, single-stranded RNA
|
Recombinant viral vector
|
Preclinical
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
Eilat virus nonstructural and CHIKV structural proteins
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
https://link.springer.com/chapter/10.1007/82_2019_175
|
NA
|
|
10405
|
CAdVax-CHIK
|
Chikungunya fever
|
Exanthous
|
Chikungunya virus
|
positive-sense, single-stranded RNA
|
Recombinant viral vector
|
Preclinical
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
Replication-deficient Ad5 encoding CHIKV structural proteins
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
https://link.springer.com/chapter/10.1007/82_2019_175
|
NA
|
|
10406
|
MVA-6KE1E3E2
|
Chikungunya fever
|
Exanthous
|
Chikungunya virus
|
positive-sense, single-stranded RNA
|
Recombinant viral vector
|
Preclinical
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
MVA encoding CHIKV structural proteins
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
https://link.springer.com/chapter/10.1007/82_2019_175
|
NA
|
|
10407
|
MVA-E2E3
|
Chikungunya fever
|
Exanthous
|
Chikungunya virus
|
positive-sense, single-stranded RNA
|
Recombinant viral vector
|
Preclinical
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
CHIKV envelope protein (E2, E3)
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
https://link.springer.com/chapter/10.1007/82_2019_175
|
NA
|
|
10408
|
MVA-CHIKV
|
Chikungunya fever
|
Exanthous
|
Chikungunya virus
|
positive-sense, single-stranded RNA
|
Recombinant viral vector
|
Preclinical
|
NA
|
NA
|
NA
|
NA
|
NA
|
Intraperitoneal
|
NA
|
CHIKV structural proteins (C, E3, E2, 6K, E1) into MVA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
https://link.springer.com/chapter/10.1007/82_2019_175
|
NA
|
|
10409
|
UV-CHIKV
|
Chikungunya fever
|
Exanthous
|
Chikungunya virus
|
positive-sense, single-stranded RNA
|
Inactivated
|
Preclinical
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
CHIKV proteins
|
Inactivated by UV-irradiation
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
https://link.springer.com/chapter/10.1007/82_2019_175
|
NA
|
|
10410
|
BEI-CHIKV
|
Chikungunya fever
|
Exanthous
|
Chikungunya virus
|
positive-sense, single-stranded RNA
|
Inactivated
|
Preclinical
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
CHIKV proteins
|
Inactivated by binary ethyleneimine
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
https://link.springer.com/chapter/10.1007/82_2019_175
|
NA
|
|
10411
|
Formalin-inactivated CHIKV
|
Chikungunya fever
|
Exanthous
|
Chikungunya virus
|
positive-sense, single-stranded RNA
|
Inactivated
|
Preclinical
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
CHIKV proteins
|
Inactivated by formalin
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
https://link.springer.com/chapter/10.1007/82_2019_175
|
NA
|
|
10412
|
Tween/Ether-CHIKV
|
Chikungunya fever
|
Exanthous
|
Chikungunya virus
|
positive-sense, single-stranded RNA
|
Inactivated
|
Preclinical
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
CHIKV proteins
|
Inactivated by Tween 80 and ether
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
https://link.springer.com/chapter/10.1007/82_2019_175
|
NA
|
|
10413
|
rCHIKVE1/E2
|
Chikungunya fever
|
Exanthous
|
Chikungunya virus
|
positive-sense, single-stranded RNA
|
Subunit vaccine
|
Preclinical
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
Recombinant E1 and E2 proteins
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
https://link.springer.com/chapter/10.1007/82_2019_175
|
NA
|
|
10414
|
rE2p
|
Chikungunya fever
|
Exanthous
|
Chikungunya virus
|
positive-sense, single-stranded RNA
|
Subunit vaccine
|
Preclinical
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
Recombinant E2 protein
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
https://link.springer.com/chapter/10.1007/82_2019_175
|
NA
|
|
10415
|
p181/25-7
|
Chikungunya fever
|
Exanthous
|
Chikungunya virus
|
positive-sense, single-stranded RNA
|
DNA based vaccine
|
Preclinical
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
CHIKV strain 181/25
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
https://link.springer.com/chapter/10.1007/82_2019_175
|
NA
|
|
10416
|
CVM1-IgG
|
Chikungunya fever
|
Exanthous
|
Chikungunya virus
|
positive-sense, single-stranded RNA
|
DNA based vaccine
|
Preclinical
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
E2-reactive monoclonal antibody
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
https://link.springer.com/chapter/10.1007/82_2019_175
|
NA
|
|
10417
|
pVax1-MCE321
|
Chikungunya fever
|
Exanthous
|
Chikungunya virus
|
positive-sense, single-stranded RNA
|
DNA based vaccine
|
Preclinical
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
CHIKV envelope proteins (E1, E2, and E3)
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
https://link.springer.com/chapter/10.1007/82_2019_175
|
NA
|
|
10418
|
DREP-Env
|
Chikungunya fever
|
Exanthous
|
Chikungunya virus
|
positive-sense, single-stranded RNA
|
DNA based vaccine
|
Preclinical
|
NA
|
NA
|
NA
|
NA
|
NA
|
Intradermal
|
NA
|
DNA replicon encoding nsP and E1, E2, E3
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
https://link.springer.com/chapter/10.1007/82_2019_175
|
NA
|
|
10419
|
GII.4 P particles
|
Norovirus Infection
|
Gastrointestinal
|
Norovirus
|
positive-sense, single-stranded RNA
|
Virus like particle
|
Preclinical
|
Cincinnati Children’s Hospital Medical Center
|
NA
|
USA
|
NA
|
NA
|
Intranasal
|
NA
|
P particles derived from HuNoV VP1
|
NA
|
NA
|
Southern Medical University, Virginia Polytechnic Institute and State University
|
NA
|
NA
|
NA
|
NA
|
https://www.mdpi.com/2076-393X/9/7/732/htm
|
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5851174/
|
|
10420
|
Plant-expressed GII.4 VLPs
|
Norovirus Infection
|
Gastrointestinal
|
Norovirus
|
positive-sense, single-stranded RNA
|
Virus like particle
|
Preclinical
|
Arizona State University
|
NA
|
USA
|
NA
|
NA
|
Intranasal
|
NA
|
HuNoV GII.4 VLP
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
https://www.mdpi.com/2076-393X/9/7/732/htm
|
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4054422/
|
|
10421
|
GII.4 VLPs combined with EV71 VLPs
|
Norovirus Infection
|
Gastrointestinal
|
Norovirus
|
positive-sense, single-stranded RNA
|
Virus like particle
|
Preclinical
|
Institut Pasteur of Shanghai
|
NA
|
China
|
NA
|
NA
|
Intramuscular
|
NA
|
HuNoV GII.4 and enterovirus 71 VLPs
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
https://www.mdpi.com/2076-393X/9/7/732/htm
|
NA
|
|
10422
|
Norovirus P particle and combination vaccines
|
Norovirus Infection
|
Gastrointestinal
|
Norovirus
|
positive-sense, single-stranded RNA
|
Subunit vaccine
|
Preclinical
|
Cincinnati Children’s Hospital Medical Center
|
NA
|
USA
|
NA
|
NA
|
Intranasal
|
Chitosan, MPL and TNC buffer
|
P domains representing different GI and GII strains
|
Baculovirus vector in E.coli or yeast system
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
https://www.cdc.gov/norovirus/downloads/global-burden-report.pdf
|
NA
|